Cloudberry Clean Energy Valuation
Is 52K undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 52K when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 52K (€0.95) is trading below our estimate of fair value (€1.29)
Significantly Below Fair Value: 52K is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 52K?
Key metric: As 52K is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 52K's PS Ratio? | |
|---|---|
| PS Ratio | 8.5x |
| Sales | NOK 385.00m |
| Market Cap | NOK 3.27b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 13x |
| Enterprise Value/EBITDA | 98.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 52K's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.5x | ||
HRPK 7C Solarparken | 2.4x | 1.9% | €154.1m |
TION Tion Renewables | 4.4x | n/a | €149.0m |
TION Tion Renewables | 4.1x | n/a | €139.5m |
ABO clearvise | 3.3x | 13.7% | €132.2m |
52K Cloudberry Clean Energy | 8.5x | 14.5% | €3.3b |
Price-To-Sales vs Peers: 52K is expensive based on its Price-To-Sales Ratio (8.5x) compared to the peer average (3.5x).
Price to Sales Ratio vs Industry
How does 52K's PS Ratio compare vs other companies in the European Renewable Energy Industry?
| 13 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 13 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: 52K is expensive based on its Price-To-Sales Ratio (8.5x) compared to the European Renewable Energy industry average (2.6x).
Price to Sales Ratio vs Fair Ratio
What is 52K's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 8.5x |
| Fair PS Ratio | 3x |
Price-To-Sales vs Fair Ratio: 52K is expensive based on its Price-To-Sales Ratio (8.5x) compared to the estimated Fair Price-To-Sales Ratio (3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €0.95 | €1.20 +26.0% | 4.5% | €1.28 | €1.11 | n/a | 5 |
| Nov ’25 | €1.00 | €1.12 +12.3% | 7.6% | €1.25 | €1.00 | n/a | 5 |
| Oct ’25 | €1.04 | €1.13 +8.3% | 8.8% | €1.28 | €1.03 | n/a | 5 |
| Sep ’25 | €1.12 | €1.13 +1.1% | 8.8% | €1.28 | €1.03 | n/a | 5 |
| Aug ’25 | €0.96 | €1.03 +6.6% | 3.4% | €1.05 | €0.96 | n/a | 5 |
| Jul ’25 | €1.05 | €0.99 -5.5% | 10.5% | €1.05 | €0.79 | n/a | 5 |
| Jun ’25 | €0.90 | €0.99 +9.9% | 11.7% | €1.11 | €0.77 | n/a | 5 |
| May ’25 | €0.75 | €1.05 +40.4% | 16.0% | €1.27 | €0.76 | n/a | 5 |
| Apr ’25 | €0.82 | €1.13 +37.1% | 12.6% | €1.31 | €0.87 | n/a | 5 |
| Mar ’25 | €0.83 | €1.15 +37.8% | 12.9% | €1.32 | €0.88 | n/a | 5 |
| Feb ’25 | €0.88 | €1.20 +37.0% | 8.5% | €1.28 | €1.02 | n/a | 5 |
| Jan ’25 | €1.02 | €1.20 +18.3% | 8.5% | €1.28 | €1.02 | n/a | 5 |
| Dec ’24 | €0.84 | €1.19 +41.5% | 8.5% | €1.26 | €1.01 | n/a | 5 |
| Nov ’24 | €0.90 | €1.17 +30.3% | 9.0% | €1.27 | €1.02 | €1.00 | 4 |
| Oct ’24 | €0.96 | €1.21 +25.9% | 9.0% | €1.30 | €1.04 | €1.04 | 4 |
| Sep ’24 | €0.88 | €1.17 +32.8% | 9.1% | €1.30 | €1.04 | €1.12 | 3 |
| Aug ’24 | €1.09 | €1.35 +24.2% | 4.1% | €1.43 | €1.29 | €0.96 | 3 |
| Jul ’24 | €1.10 | €1.29 +16.4% | 4.9% | €1.35 | €1.22 | €1.05 | 2 |
| Jun ’24 | €1.04 | €1.29 +23.1% | 4.9% | €1.35 | €1.22 | €0.90 | 2 |
| May ’24 | €0.88 | €1.71 +94.7% | 10.1% | €1.83 | €1.46 | €0.75 | 3 |
| Apr ’24 | €1.02 | €1.71 +67.4% | 10.1% | €1.83 | €1.46 | €0.82 | 3 |
| Mar ’24 | €1.01 | €1.71 +69.0% | 10.1% | €1.83 | €1.46 | €0.83 | 3 |
| Feb ’24 | €1.06 | €1.87 +76.5% | 4.9% | €1.94 | €1.74 | €0.88 | 3 |
| Jan ’24 | €1.15 | €1.87 +63.2% | 4.9% | €1.94 | €1.74 | €1.02 | 3 |
| Dec ’23 | €1.25 | €1.87 +49.4% | 4.9% | €1.94 | €1.74 | €0.84 | 3 |
| Nov ’23 | €1.21 | €1.87 +54.9% | 4.9% | €1.94 | €1.74 | €0.90 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Centrica
UK£6.4b
Operates as an integrated energy company in the United Kingdom, Ireland, Scandinavia, North America, and internationally.
CENB
UK£1.48
7D
1.9%
1Y
-11.5%
Sembcorp Industries
S$9.3b
An investment holding company, engages in the production and supply of utilities services, and terminalling and storage of petroleum products and chemicals in Singapore, the United Kingdom, China, India, rest of Asia, the Middle East, and internationally.
SBOA
S$3.62
7D
1.1%
1Y
5.2%
AB Ignitis grupe
€1.4b
Engages in the generation and distribution of electricity and heat.
IGV0
€18.64
7D
0%
1Y
-2.8%